2026-10-25
Zebra Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,906 −5.38%
S&P 7,400 −3.75%
GOLD $4,127 +1.33%
BTC $76,159 −5.28%
VIX 24.13 +45.27%
latest tape · as of 20:03 UTC · 5 Nov
The Screen · Technology · Communication Equipment
Zebra Technologies
ZBRA · a US exchange · USD · Market cap $17.2B · 10,700 employees
Zebra Technologies Corporation, together with its subsidiaries, operates in the automatic identification and data capture solutions industry worldwide.
Not yet scored332.44 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 20:03 UTC · 5 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price332.44 USD at the 4 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 4 Nov 2026
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.26)
- Last reviewed4 Nov 2026 (2 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $434.71 to $664.88, base estimate $460.00 (screen dated 2026-11-04).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 1.26, read 2026-11-05
- Ethical screen not yet scored
Price332.44 USD
Fair value460.00
Ethical score85.3/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-02Read Accumulation375.97-11.6% to today Markdown gives way to Accumulation after a 9% rise in 2 weeks
2026-09-18Read Markdown344.01-3.4% to today ✓Markup gives way to Markdown after a 48% rise in 11 weeks
2026-07-02Read Markup232.11+43.2% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Zebra Technologies holds its Distribution at $332.44. Consolidating, no directional conviction, held for 37 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 37 days |
| Price at the screen | $332.44 |
| Valuation | 33.11 trailing · 16.21 forward price to earnings |
| Values screen | Not scored · score 85.3 |
| Beta | 1.58 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 31.72% | Below 33% | Interest-bearing debt is just 31.7% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 10.89% | Below 49% | Money owed to the company is 10.9% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Zebra Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Zebra Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 32%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 28% discount to our $460.00 fair value, narrow competitive moat, 20.40% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 27.7% discount to the base estimate.
Third-party analyst targets: 15 covering, consensus Buy. The average target sits +26% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $460.00, with a range of $434.71 to $664.88, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it stands out
A 20%-growth business trading at just 16.2x forward earnings, with a narrow competitive moat. That is a 28% discount to our $460.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 15 analysts rate it Buy with a $420.00 average target, about 26% above the screened price.
| Forward P/E | 16.2xfairly priced for its growth rate |
| Trailing P/E | 33.1xa premium valuation |
| EPS, trailing | 10.91 |
| EPS, forward | 22.29 |
| Revenue growth | +20.4%strong top-line growth |
| Profit margin | 9.2%thin but positive margins |
| Return on equity | 15.3%a solid return on shareholder capital |
| FCF yield | 3.35% |
| Debt to equity | 0.86moderate, manageable leverage |
| Current ratio | 0.52below 1: short-term bills exceed liquid assets |
| Beta | 1.58much more volatile than the market |
| Short interest, float | 0.04% |
| 52-week range | 199.05 - 392.78 |
| Moat | NARROW |
| Market cap | $17.2B |
| Employees | 10,700 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeZBRA trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-03
Accumulation $361.26
+0.0% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $361.26
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation $361.26
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $361.26
-6.5% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 6.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $386.45
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $386.45
+4.7% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $369.01
+0.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Accumulation $369.01
+0.0% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Accumulation $369.01
-4.7% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 35% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329.
2026-10-14
Accumulation $387.18
+3.0% Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $329.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Can ZBRA's Strong Cash Generation Drive More Growth and Returns? Yahoo Finance · 7d ago
- /C O R R E C T I O N - MSM Solutions/ Yahoo Finance · 7d ago
- Is Zebra Technologies Stock a Smart Buy Before Q3 Earnings Release? Yahoo Finance · 8d ago
- Zebra Technologies (ZBRA) Was a Top Contributor for Ariel Fund on Strong Earnings and Automation Demand Yahoo Finance · 8d ago
- Elo Adds Zebra DataWedge Support to Simplify Enterprise Data Capture Yahoo Finance · 9d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
ASTSAST SpaceMobile Inc
VIAVViavi Solutions Inc
VSATViasat Inc
ERICTelefonaktiebolaget L M Ericsson ADR
UIUbiquiti Inc
CIENCiena
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | ROBERTS JANICE M | Director | 3,000 | $748,620 | |
| 2026-04-08 | BURNS WILLIAM | Chief Executive Officer | 358 | · | |
| 2026-04-07 | GUSTAFSSON PER ANDERS | Director | 32,862 | $1,813,493 | |
| 2026-03-12 | DHANASEKARAN SATISH | Director | 200 | $41,080 | |
| 2026-03-05 | KOGL CRISTEN L | Officer | 145 | $34,178 | |
| 2026-03-05 | ARMSTRONG ROBERT JOHN JR | Officer | 9 | $2,068 | |
| 2026-03-05 | WINTERS NATHAN ANDREW | Chief Financial Officer | 33 | $6,769 | |
| 2026-03-05 | ARMSTRONG ROBERT JOHN JR | Officer | 17 | $3,487 | |
| 2026-03-05 | KOGL CRISTEN L | Officer | 287 | $58,869 | |
| 2026-03-03 | FROESE TAMARA DIONNE | Officer | 2,412 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-05-15 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-05-01 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $216.96 | -0.1% | · | $999 | -0.1% |
| 2 months | $222.13 | -2.4% | · | $976 | -2.4% |
| 3 months | $204.05 | +6.2% | · | $1,062 | +6.2% |
| 6 months | $273.54 | -20.8% | · | $793 | -20.8% |
| 1 year | $299.56 | -27.6% | · | $724 | -27.6% |
| 2 years | $302.60 | -28.4% | · | $716 | -28.4% |
| 3 years | $274.66 | -21.1% | · | $789 | -21.1% |
| 5 years | $508.48 | -57.4% | · | $426 | -57.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ZBRA does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.